05 Compliance

The regulatory file for L-phenylalanine

Technical document 05 · Reviewed 2026-11-19 · L-Phenylalanine

On this page
  1. The four checks
  2. European Union
  3. United States
  4. United Kingdom
  5. Contaminants and limits
  6. The claim boundary
  7. The document file
  8. Checklist before the first order

L-Phenylalanine is sold as a food and supplement ingredient, and the file behind it answers four separate questions: whether the form may be sold in the destination, what the contaminant ceiling is for the finished product, how the label names the ingredient, and whether any claim is allowed. The EU, the US and the UK answer those in different instruments, so the buyer's regulatory team confirms the route. This page lists the framework, documents and checks; it is a sourcing reference, not legal advice.

In one line

The ingredient status, the contaminant ceiling, the phenylalanine declaration and the claim are four separate checks, and each market signs them off in its own instrument.

The four checks

The first question is whether the ingredient may be placed on the market at all. The second is whether the finished product stays under the contaminant limits at the daily dose. The third is whether the label names the ingredient and the amount correctly, including any statement that the presence of phenylalanine requires. The fourth is whether a health claim attached to it is authorised and substantiated. A batch certificate supports all four and replaces none of them, and the operator placing the product on the market owns the file.

European Union

Directive 2002/46/EC harmonises food supplements, but its positive list in Annex II covers vitamins and minerals, not amino acids. L-Phenylalanine therefore sits under general food law, Regulation (EC) No 178/2002, together with any national rules the destination Member State applies; several have their own notification or composition requirements. The label follows Regulation (EU) No 1169/2011 and the supplement particulars of the Directive.

The novel-food position is checked for the exact form. The amino acid has a long history of food use, so the expectation is a pre-15 May 1997 history rather than an authorisation, but the entry for the form should be confirmed in the EU Novel Food Catalogue as of the review date. The racemate and the D form are different ingredients and do not inherit that history.

United States

L-Phenylalanine is a dietary ingredient under DSHEA, and the supplier should be able to support the position that it was marketed in the US before 15 October 1994; an ingredient in that position does not need a new dietary ingredient notification. The finished product is made under 21 CFR 111 and labelled under 21 CFR 101.36, and the FDA does not approve supplements or their ingredients before sale, so the file is the evidence.

A structure/function claim is allowed if it is truthful, not misleading and substantiated, with the DSHEA disclaimer and a notification to the FDA within 30 days after marketing. A claim that names a disease is outside that route, and advertising is subject to FTC substantiation as well. A food use rather than a supplement use is a different route and should be checked before the claim is written.

United Kingdom

Great Britain applies retained food law and the GB register, and Northern Ireland follows the EU framework under the Windsor Framework. The two are checked separately, and the label, the limits and the novel-food position are confirmed against the GB text rather than the EU one.

Contaminants and limits

The contaminant panel is a finished-product calculation, not only a drum result. The table is the starting point; the destination text and the daily dose decide the final figure.

Contaminant limits for L-phenylalanine and the finished product
ParameterCatalog limit, raw materialFinished-product referenceWhat to confirm
Lead (Pb)≤3 mg/kg3.0 mg/kg in the supplement · EU and UKHeadroom for other ingredients and method uncertainty
Cadmium (Cd)≤1 mg/kg1.0 mg/kg, with category exceptionsThe category that applies to the product
Mercury (Hg)≤0.1 mg/kg0.10 mg/kgThe method and its limit of quantification
Arsenic (As)≤2 mg/kgNo harmonised supplement limitThe buyer's own limit and the test behind it
MicrobiologyAPC ≤1,000 cfu/g; E. coli and Salmonella absentHygiene criteria for the finished productThe finished-product test, not only the drum

The EU and UK ceilings apply to the food as placed on the market, so a raw-material limit set at the ceiling leaves no room for the other ingredients in the capsule. The dose also converts the material limit into a daily intake: 500 mg at the lead ceiling of 3 mg/kg contributes 1.5 µg of lead, above the 0.5 µg per day maximum allowable dose level that California's Proposition 65 sets. A supplier limit below the ceiling is a purchasing decision, not a formality.

The claim boundary

In the EU and the UK, a health claim must be authorised and appear in the applicable Register, and Regulation (EC) No 1924/2006 also requires it to be truthful, clear and substantiated. As of this review the EU Register does not carry an authorised claim for phenylalanine as such. A protein claim belongs to the protein content, not to an added amino acid, and the conversion of phenylalanine to tyrosine is a biochemical statement rather than an authorised claim.

In the US, a structure/function claim is possible under DSHEA with the disclaimer and the notification, but a disease claim is not. In all three markets a claim describes the ingredient named on the label, and the form matters: a claim written for L-phenylalanine does not transfer to a DL product by editing the ingredient list.

The document file

Documents a brand should hold for an L-phenylalanine lot
DocumentWhat it supportsMarket
Batch certificate of analysisRelease against the specification, with methods and resultsAll
SpecificationThe agreed limits, methods and the dried basisAll
Technical data sheetSolubility, particle size, storage and packAll
Safety data sheetHazard and handling informationAll
Allergen and GMO statementsComposition and labelling declarationsEU, UK, US
Enantiomer and rotation statementThe L form, with method and resultAll
Origin and manufacturer statementTraceability and the production routeAll
Heavy-metal and microbiology reportsThe contaminant and hygiene envelopeAll
Label declaration reviewThe phenylalanine statement and the claim wordingEU, UK, US

Checklist before the first order

  1. Name the enantiomer and match CAS 63-91-2; DL and D are different ingredients.
  2. Confirm the market entry position for that form, including Member State rules and the GB register.
  3. Set raw-material contaminant limits below the finished-product ceiling, and keep an arsenic limit because the EU and the UK do not set one.
  4. Convert the figures to the daily dose and check the US state thresholds.
  5. Check whether a phenylalanine statement is required, and have the wording reviewed.
  6. Check every claim against the Register or the DSHEA route.
  7. Collect the documents against the lot number, not the product name alone.

The release tests are on the COA page, the form choice on the L versus DL page, and the identity evidence on the identity page. The adjacent aromatic amino acid is on the L-tyrosine page; the framework references are in the EU, US and UK notes; the release file is described on the quality page; the catalog specification is on the product page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation